From April 1, 2024 to April 30, 2024, the company has repurchased 4,209,500 shares, representing 0.41% for CNY 18.53 million. With this, the company has completed the repurchase of 22,174,904 shares, representing 2.16% for CNY 102.76 million under the buyback announced on February 6, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.8 CNY | -1.81% |
|
-2.56% | -43.70% |
May. 20 | Shanxi Zhendong Pharmaceutical Co.,Ltd Approves Board Appointments | CI |
May. 06 | Tranche Update on Shanxi Zhendong Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on February 6, 2024. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.70% | 547M | |
+55.95% | 811B | |
+43.62% | 640B | |
-6.98% | 353B | |
+19.08% | 333B | |
+9.05% | 302B | |
+16.30% | 246B | |
+2.41% | 225B | |
+12.47% | 218B | |
+8.91% | 168B |
- Stock Market
- Equities
- 300158 Stock
- News Shanxi Zhendong Pharmaceutical Co.,Ltd
- Tranche Update on Shanxi Zhendong Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on February 6, 2024.